推进肠道菌群研究,学科融合赋能药学发展
Advancing Gut Microbiota Research and Fostering Interdisciplinary Integration to Empower Pharmaceutical Development
潘利斌 1方罗 1王琰2
作者信息
- 1. 浙江省肿瘤医院,杭州 310022
- 2. 中国医学科学院北京协和医学院药物研究所,北京 100050
- 折叠
摘要
近年来,肠道菌群一直是科学研究的前沿热点,特别是从肠道菌群角度研究药物药效和机制,肠道菌群为药学研究注入了全新的视角和方向.为持续推动药学创新,合力攻关药学难题,本章推出"肠道菌群研究"专刊,促进多学科融合赋能药学发展.将为广大药学研究同道提供肠道菌群视角下临床借鉴、研究基础和思路拓展,进一步促进药学学科的蓬勃发展.
Abstract
In recent years,the gut microbiota has been a frontier hotspot in scientific research,particularly in studying the pharmacodynamics and mechanisms of drugs from the perspective of gut microbiota,which has injected a new perspective and direction into pharmaceutical research.To continuously drive pharmaceutical innovation and jointly tackle challenging issues in this field,this chapter introduces a special issue on"intestinal flora research",aiming to promote multidisciplinary integration and empower the development of pharmaceutical sciences.It will provides extensive pharmaceutical research colleagues with clinical insights,research foundations,and expanded thinking from the perspective of gut microbiota,further promoting the vigorous development of pharmaceutical disciplines.
关键词
肠道菌群/药学研究/药物药效Key words
gut microbiota/pharmaceutical research/pharmacological efficacy引用本文复制引用
出版年
2024
NETL
NSTL
万方数据